DLK1 and Nesfatin-1 levels and the relationship with metabolic parameters in polycystic ovary syndrome: Prospective, controlled study
- PMID: 34083652
- PMCID: PMC8191326
- DOI: 10.4274/tjod.galenos.2021.39024
DLK1 and Nesfatin-1 levels and the relationship with metabolic parameters in polycystic ovary syndrome: Prospective, controlled study
Abstract
Objective: Delta-like 1 (DLK1) is known to inhibit adipocyte differentiation and nesfatin-1 is a neuropeptide that plays a role in the regulation of nutrition and metabolism. We aimed to assess both the levels of DLK1 and nesfatin-1 in polycystic ovary syndrome (PCOS) and determine the association of DLK1 and nesfatin-1 with metabolic parameters.
Materials and methods: Forty-four patients with PCOS and 40 healthy women as the control group were included in this study. Venous blood samples of the participants were collected, and hormonal, metabolic parameters, DLK1 and nesfatin-1 blood levels were determined. Anthropometric parameters were also determined. For a double comparison, the Mann-Whitney U test was used for non-parametric numerical data, and Student's t-test was used for parametric numerical data. Bivariate correlations were investigated using Spearman's correlation analysis. The diagnostic performance of the parameters was evaluated using receiver operating characteristic curve analysis.
Results: The findings showed that DLK1 and nesfatin-1 levels were lower among the PCOS group, and the differences in these values were found to be statistically significant. A significant negative correlation was found between DLK1 levels and body mass index (BMI), waist/hip ratio, visceral adiposity index (VAI), fasting serum insulin (FSI), homeostasis model of assessment-insulin resistance (HOMA-IR) and triglyceride levels. A significant negative correlation was found between nesfatin-1 levels and BMI, VAI, FSI, HOMA-IR and triglyceride.
Conclusion: The findings showed that DLK1 and nesfatin-1 levels were lower in PCOS. Based on this study, DLK1 may be culpable for metabolic disorders in PCOS and can be a novel marker for PCOS in the future.
Keywords: Polycystic ovary syndrome; delta-like 1; insulin resistance; nesfatin-1; visceral adiposity index.
Conflict of interest statement
Figures
Similar articles
-
Visceral adiposity index levels in overweight and/or obese, and non-obese patients with polycystic ovary syndrome and its relationship with metabolic and inflammatory parameters.J Endocrinol Invest. 2017 May;40(5):487-497. doi: 10.1007/s40618-016-0582-x. Epub 2016 Nov 12. J Endocrinol Invest. 2017. PMID: 27838846
-
Metabolically healthy polycystic ovary syndrome (MH-PCOS) and metabolically unhealthy polycystic ovary syndrome (MU-PCOS): a comparative analysis of four simple methods useful for metabolic assessment.Hum Reprod. 2013 Jul;28(7):1919-28. doi: 10.1093/humrep/det105. Epub 2013 Apr 16. Hum Reprod. 2013. PMID: 23592224
-
Maternal Serum Delta-Like 1 and Nesfatin-1 Levels in Gestational Diabetes Mellitus: A Prospective Case-Control Study.Cureus. 2021 Aug 8;13(8):e17001. doi: 10.7759/cureus.17001. eCollection 2021 Aug. Cureus. 2021. PMID: 34540403 Free PMC article.
-
Nucleobindin-2 derived nesfatin-1 in polycystic ovary syndrome: a PRISMA and GRADE-compliant systematic review and meta-analysis with diagnostic test accuracy.Minerva Endocrinol (Torino). 2024 Mar;49(1):111-121. doi: 10.23736/S2724-6507.23.04003-4. Epub 2023 Nov 9. Minerva Endocrinol (Torino). 2024. PMID: 37943280
-
Circulating nesfatin-1 levels in women with polycystic ovary syndrome: A systematic review and meta-analysis.Int J Reprod Biomed. 2023 Nov 24;21(10):777-788. doi: 10.18502/ijrm.v21i10.14533. eCollection 2023 Oct. Int J Reprod Biomed. 2023. PMID: 38077942 Free PMC article. Review.
Cited by
-
The Role of the Gastric Hormones Ghrelin and Nesfatin-1 in Reproduction.Int J Mol Sci. 2021 Oct 14;22(20):11059. doi: 10.3390/ijms222011059. Int J Mol Sci. 2021. PMID: 34681721 Free PMC article. Review.
-
Shared Pathophysiological Mechanisms and Genetic Factors in Early Menarche and Polycystic Ovary Syndrome.J Neurosci. 2025 Mar 12;45(11):e1681242024. doi: 10.1523/JNEUROSCI.1681-24.2024. J Neurosci. 2025. PMID: 40074331 Review.
-
Blood nesfatin-1 levels in patients with polycystic ovary syndrome: a systematic review and meta-analysis.Front Endocrinol (Lausanne). 2024 Jan 24;14:1275753. doi: 10.3389/fendo.2023.1275753. eCollection 2023. Front Endocrinol (Lausanne). 2024. PMID: 38327900 Free PMC article.
-
Clinico-Metabolic Profile in Lean Versus Obese Polycystic Ovarian Syndrome Women.Cureus. 2023 Apr 19;15(4):e37809. doi: 10.7759/cureus.37809. eCollection 2023 Apr. Cureus. 2023. PMID: 37214034 Free PMC article.
-
Review of Novel Potential Insulin Resistance Biomarkers in PCOS Patients-The Debate Is Still Open.Int J Environ Res Public Health. 2022 Feb 13;19(4):2099. doi: 10.3390/ijerph19042099. Int J Environ Res Public Health. 2022. PMID: 35206286 Free PMC article. Review.
References
-
- Shannon M, Wang Y. Polycystic ovary syndrome: a common but often unrecognized condition. J Midwifery Womens Health. 2012;57:221–30. - PubMed
-
- Brakta S, Lizneva D, Mykhalchenko K, Imam A, Walker W, Diamond MP, et al. Perspectives on polycystic ovary syndrome: is polycystic ovary syndrome research underfunded? J Clin Endocrinol Metab. 2017;102:4421–7. - PubMed
-
- Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81:19–25. - PubMed
-
- Gomes LG, Cunha-Silva M, Crespo RP, Ramos CO, Montenegro LR, Canton A, et al. DLK1 is a novel link between reproduction and metabolism. J Clin Endocrinol Metab. 2019;104:2112–20. - PubMed
LinkOut - more resources
Full Text Sources